PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/2817/12/15
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bausch & Lomb
ALK-Abelló alleged Bausch & Lomb UK failed to comply with an undertaking given in an earlier case (AUTH/2802/11/15) about using the word “new” in promotion of Emerade (adrenaline auto-inje…
Clauses: 3.2,4.2
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2804/11/15
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Merck Serono
An anonymous, non-contactable complainant (self-described senior neurologist) alleged persistent rep approaches (including to MS nurses) and pressure to attend meetings with no information, and sug…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2793/9/15
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
AstraZeneca Forxiga EMIS Web ‘9 step guide’ ruled misleading; corrective statement and public reprim
A clinical pharmacist complained about an AstraZeneca leavepiece giving EMIS Web instructions to identify “uncontrolled and overweight” type 2 diabetes patients who “may be suitable” for Fo…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2792/9/15
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous complainant (described themself as a respiratory physician) alleged a GlaxoSmithKline (GSK) corporate press release about the SUMMIT COPD study was deliberately misleading.The press re…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2787/8/15
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
GlaxoSmithKline (GSK) voluntarily admitted that some UK online advertisements for Incruse Ellipta (umeclidinium bromide) plus Relvar Ellipta (fluticasone furoate/vilanterol trifenatate) did not mee…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2786/8/15
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Keppra medical information email reposted on ESNA website
An NHS medicines information pharmacist complained about content on the Epilepsy Nurse Association (ESNA) website titled “Data on Keppra v generic levetiracetam”.The ESNA page reproduced text f…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2785/8/15
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer
An anonymous, non-contactable consultant complained about Bayer’s promotion of Eylea (aflibercept), alleging discussions comparing Eylea with Lucentis (ranibizumab) using off-licence/off-label da…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2756/5/15
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Merck Serono call-rate targets
An anonymous employee complained that, after a neurology leadership change (Jan 2015), the neurology sales team was targeted to see six prescribing customers daily.What began as a March 2015 “add…
Clauses: 9.1,9.2
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2763/5/15
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
AstraZeneca
An ABPI-funded paper in Current Medical Research & Opinion (published online 5 May 2015) assessed whether results of company-sponsored trials linked to new medicines approved by EMA in 2012 wer…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2753/3/15
Social Media & Digital Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
ViiV Healthcare
ViiV Healthcare UK voluntarily admitted that the February 2015 printed edition of the International Journal of STD and Aids contained a double-page Triumeq (dolutegravir/abacavir/lamivudine) advert…
Clauses: 9.1
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2746/1/15
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca tweet on early breast cancer progression
A director of research (US-based, with a UK medical licence) complained about an AstraZeneca tweet posted on 11 December 2014 from the San Antonio Breast Cancer Symposium (#SABCS14).The tweet state…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2811/12/15
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Daiichi-Sankyo photo booth at ESC Congress
An anonymous, non-contactable complainant alleged that exhibition stands at a European congress in London (ESC Congress 2015) were extravagant and created a “party atmosphere”, citing Daiichi-S…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2772/6/15
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Actavis
A matter was raised under Paragraph 5.1 by the PMCPA Director against Actavis.The issue related to clinical trial disclosure for Zinforo (marketed as Teflaro in the USA).The PMCPA determined the ma…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2743/12/14
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Amdipharm Mercury
A community/superintendent pharmacist received a patient query (11 Dec 2014) about levothyroxine brand; the patient reported having had “issues” with product manufactured by Amdipharm Mercury a…
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2741/12/14
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Chiesi SOP training criticised as a ‘tick-box’ validation exercise ahead of PMCPA audit (AUTH/2741/1
A representative complained about SOP training for a primary care sales team run by a regional business manager (RBM) in October 2014, shortly before a PMCPA audit.The complainant alleged the sessi…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2739/11/14
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
Pfizer complained on behalf of itself and Bristol-Myers Squibb (the Alliance) about a Daiichi-Sankyo UK Ltd satellite symposium/workshop at the Pharmacy Management National Forum (18 November 2014)…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2738/10/14
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Boehringer Ingelheim
Boehringer Ingelheim Corporate (Germany) sent a LinkedIn InMail on 13 August 2014 to a global audience (including some UK recipients) headed “Read new data on treatment outcomes with Giotrif”.T…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2728/8/14
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Anonymous prescriber complaint about Relvar Ellipta pneumonia risk messaging (No breach)
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2726/8/14
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK Seretide
An anonymous, non-contactable health professional complained about GlaxoSmithKline UK’s use of the TORCH study (Calverley et al 2007) in promotional materials for Seretide (salmeterol/fluticasone…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2732/9/14
Social Media & Digital Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen
Janssen sent a ‘Dear Doctor’ letter about Invokana (canagliflozin) to GPs across 150 clinical commissioning groups (CCGs).The letter headline and opening stated Invokana had been approved by th…
Clauses: 9.1,9.2
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2725/7/14
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
An anonymous but contactable member of the public complained about a Daily Mirror print and online article: “Young cancer patient forced to pay £2,000 a week for treatment drugs – after NHS re…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2723/7/14
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Napp Pharmaceuticals
A consultant psychiatrist complained about Napp’s BuTrans (buprenorphine transdermal patch) promotional campaign focused on pain in patients with dementia.Materials included: a BMJ advertisement …
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2694/1/14
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Anonymous v Pharmacosmos (AUTH/2694/1/14)
An anonymous, contactable complainant challenged Monofer (iron (III) isomaltoside 1000) content across two linked sites: the UK corporate site (pharmacosmos.co.uk) and the product site (monofer.com…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2717/5/14
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche voluntary admission after MabThera journal advertising appeared on four pages (Clause 6.3)
Roche voluntarily admitted that an edition of the British Journal of Haematology (BJH) carried advertising for MabThera (rituximab) on four pages.The May-II (19 May) BJH edition contained two separ…
Clauses: 6.2
2014 🔒 Subscribe
← Prev 20 21 22 23 24 25 26 Next → Page 23 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews